These have supported an ever‐growing list of in vitro human functional and genetic studies that have associated DR‐3 and TL1A with human diseases ranging from inflammatory bowel disease (IBD) and primary biliary cirrhosis to leprosy (comprehensively reviewed in ref.41). The gene discussed is TNFRSF25; the disease is inflammatory bowel disease.